Severe COVID‐19 infection results in bilateral interstitial pneumonia, often leading to acute
respiratory distress syndrome (ARDS) and pulmonary fibrosis in survivors. Most patients with …

A number of medicines are currently under investigation for the treatment of COVID-19
disease including anti-viral, anti-malarial and anti-inflammatory agents. While these …

The COVID-19 pandemic has become a serious concern and has negatively impacted
public health and the economy. It primarily targets the lungs, causing acute respiratory …

Extracellular vesicles (EVs) have emerged as potential mediators of intercellular
communication. EVs are nano-sized, lipid membrane–bound vesicles that contains …

The COVID-19 pandemic has negatively impacted the global public health and the
international economy; therefore, there is an urgent need for an effective therapy to treat …

Acute respiratory distress syndrome (ARDS) is a serious and potentially fatal acute
inflammatory lung condition which currently has no specific treatments targeting its …

Background: The outbreak of severe acute respiratory syndrome β-coronavirus 2 (SARS-
CoV-2) has the potential to become a long-lasting global health crisis. The number of people …

In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan city, Hubei province,
China. Rapidly escalated into a worldwide pandemic, it has caused an unprecedented and …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a member of the
coronaviridae that causes respiratory disorders. After infection, large amounts of …

Acute respiratory distress syndrome (ARDS) is the main cause for the COVID-19 infection-
related morbidity and mortality. Recent clinical evidences suggest increased level of …